|
| ID |
DDInter1070 |
| Drug Type |
small molecule |
| Molecular Formula |
C25H28N8O2 |
| Molecular Weight |
472.553
|
| Description |
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
|
| ATC Classification |
A10BH05
A10BD19
A10BD11
|
| IUPAC Name |
8-[(3R)-3-Aminopiperidin-1-Yl]-7-(But-2-Yn-1-Yl)-3-Methyl-1-[(4-Methylquinazolin-2-Yl)Methyl]-2,3,6,7-Tetrahydro-1H-Purine-2,6-D |
| InChI |
Inchi=1S/C25H28N8O2/C1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/H6-7,10-11,17H,8-9,12-15,26H2,1-3H3/T17-/M1/S1 |
| InChI Key |
LTXREWYXXSTFRX-QGZVFWFLSA-N |
| Canonical SMILES |
CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|